Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BILN 2061 ZW in Chronic Hepatitis C
NCT02226952Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2001
- Primary completion
- Apr 2002
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ciluprevir in hepatitis C virus infection, sponsored by Boehringer Ingelheim. Started Nov 2001; status: completed.
02
Drugs
ciluprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT02226952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02226952.